Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A case of pancreatic neuroendocrine tumors.
Moriyama M, Matsumoto Y, Zhou Q, Yamana K, Ikeda Y, Ayukawa F, Abe E, Sato S, Takano K, Kaidu M, Aoyama H, Saijo Y. Moriyama M, et al. Among authors: yamana k. Int Cancer Conf J. 2015 Jul 3;5(1):1-4. doi: 10.1007/s13691-015-0230-x. eCollection 2016 Jan. Int Cancer Conf J. 2015. PMID: 31149413 Free PMC article.
Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.
Ueda T, Koga Y, Yoshikawa H, Tanabe M, Yamana K, Oba U, Nakashima K, Ono H, Ichimura T, Hasegawa S, Kato W, Kobayashi T, Nakayama H, Sakai Y, Yoshitake T, Ohga S, Oda Y, Suzuki S, Sonoda KH, Ohga S. Ueda T, et al. Among authors: yamana k. BMC Pediatr. 2020 Jan 28;20(1):37. doi: 10.1186/s12887-020-1923-7. BMC Pediatr. 2020. PMID: 31992242 Free PMC article.
Two Cases of Angiosarcoma with Persistent Unilateral Eyelid Swelling.
Sakisaka S, Tanabe M, Imayama S, Zeze N, Yamana K, Yoshikawa H, Sonoda KH. Sakisaka S, et al. Among authors: yamana k. Ocul Oncol Pathol. 2022 Feb;8(1):16-21. doi: 10.1159/000520293. Epub 2021 Oct 21. Ocul Oncol Pathol. 2022. PMID: 35356598 Free PMC article.
Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant.
Win KHN, Kushida Y, Yamana K, Iwatani S, Yoshida M, Nino N, Mon CY, Ohsaki H, Kamoshida S, Fujioka K, Dezawa M, Nishimura N. Win KHN, et al. Among authors: yamana k. Stem Cell Res Ther. 2024 May 22;15(1):147. doi: 10.1186/s13287-024-03763-8. Stem Cell Res Ther. 2024. PMID: 38773627 Free PMC article.
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, Bando Y, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Tatarano S, Masui K, Matsuda A, Kaneko T, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. Tomida R, et al. Among authors: yamana k. Clin Genitourin Cancer. 2024 Apr 15:102094. doi: 10.1016/j.clgc.2024.102094. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38714434
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group. Matsushita Y, et al. Among authors: yamana k. Int J Urol. 2024 May;31(5):526-533. doi: 10.1111/iju.15396. Epub 2024 Jan 19. Int J Urol. 2024. PMID: 38240169
361 results